I am a Professor in the
School of Engineering and Technology at University of Washington - Tacoma, and
an Adjunct Professor in the Department of Microbiology at University of Washington - Seattle.
I also serve as the Associate Dean for Research and Innovation at the School
of Engineering and Technology at University of Washington Tacoma.
My research focuses on the development of optimized methods and cloud-based software tools for the analyses of big biomedical data.
My group has expertise in next generation sequencing, long read sequencing and imaging data.
My research experience includes bioinformatics, machine learning, data science, systems biology, cancer genomics, and precision medicine.
I am strongly committed to enhancing the diversity of the STEM workflorce.
I am a computer scientist by training (Ph.D. in Computer Science from University of Washington - Seattle under the supervision of Larry Ruzzo), and have extensive experience in interdisciplinary collaborative projects.
NEW: Our lab is part of the NIH MorPhiC consortium. We are currently recruiting at all levels: PhD students, Master's students, undergraduate students, and have an open postdoc position in bioinformatics. Please reach out to me via email if interested.
Publications Software Data Teaching Curriculum vitae
Email me
Last Update: 1/3/2023
Osage University Partners Inspiring Academic Female Founders, June 13, 2022.
UW CoMotion Celebrating UW Asian/Pacific American Innovators, May 25, 2022.
UW CoMotion Celebrating UW women innovators, March 30, 2021.
UW eScience seminar Building containerized workflows using the BioDepot-workflow-builder, Feb 4, 2021.
'Serverless' Cloud Technology Dramatically Accelerates RNA-Seq Alignment Time: featured in genomeweb, Dec 8, 2020.
Promoting inclusion and diversity in research: featured in Diversity In Action magazine, March/April 2020.
UW CoMotion Innovation Gap Fund: Winners Announced. December 11, 2019.
UW CoMotion: Researcher Spotlight. November 22, 2019.
Presentation of Distinguished Research Award at University of Washington Tacoma Video. Oct 4, 2019.
New software will transform biological data analysis. An NIH-funded team at UW Tacoma, led by Dr. Ka Yee Yeung, has launched BioDepot-workflow-builder to move bioinformatics data analysis into the cloud. Sept 26, 2019. Full article.
UW Tacoma's Dr. Ka Yee Yeung-Rhee, Ph.D, is working with Dr. Pamela Becker, a UW Medicine hematologist who specializes in blood cancer research. Dr. Yeung-Rhee, a big-data expert, is looking for statistical patterns in cancer patients' genetic mutations and the drugs they respond to. More
Madigan pairs with UW to improve medicine, by Suzanne Ovel, Northwest Guardian, Jan. 5, 2017. Full article
Reproducible, interactive and scalable workflows:
Our goal is to create easy-to-use and easy-to-deploy cloud-enabled tools for the creation, sharing and execution of reproducible bioinformatics workflows.
Our latest work BioDepot-workflow-builder (Bwb) allows biomedical scientists to create, share and reproducibly execute bioinformatics workflows in a point-and-click user interface.
Bwb supports RNA-seq, DNA-seq, and nanopore workflows.
Related manuscripts:
BMC Genomics 2021,
Cell Systems 2019,
JAMIA 2018,
PLOS One 2016, 11(4):e0152686,
Gigascience 2017, 6(4)1-6,
bioRxiv 144816,
Related GitHub:
BioDepot-workflow-builder (Bwb),
Bioconductor notebooks
Summer Institute for Research Education in Bioinformatics and Biostatistics:
This is a 3-week training program for undergraduate students interested in learning the basics of bioinformatics, biostatistics, statistical computing and data science.
This summer program consists of one week of lectures and labs, followed by hands-on project experience over a two-week period. At the end of the program, participants will present the results of their group projects, and network with existing professionals, faculty and graduate students in bioinformatics and biostatistics.
For more information:
BioSummer School 2018
NIH LINCS consortium:
I served as an external data science collaborator on a NIH-funded BD2K-LINCS Perturbation Data Coordination and Integration Center (DCIC) from 2014 to 2018.
The NIH LINCS project is
generating millions of experiments, measuring the cell's response to drug
and genetic perturbations. We work with other investigators in the LINCS consortium to develop computational methods
and tools to build predictive models of complex diseases and drug responses.
Related work:
Mathematical Biosciences and Engineering 2016, 13(6):1241-1251,
arXiv:1602.06316,
bioRxiv 099028,
bioRxiv 099010
Network inference from diverse genomics data:
Interactions among genes and their gene products comprise a regulatory network.
The goal of network inference is to generate testable hypotheses of gene-to-gene influences and subsequently design bench experiments to confirm network predictions.
In the November 2011 issue of PNAS, Yeung and colleagues presented a methodology to construct gene
regulatory networks from time series expression data in yeast,
integrating various types
of external biological knowledge available from public repositories.
We generated microarray data measuring time-dependent gene-expression levels in
95 genotyped yeast segregants subjected to a drug perturbation.
Our algorithm is capable of generating feedback loops and we showed that the
inferred network recovered existing and novel regulatory relationships.
In addition, we generated independent microarray data on selected deletion
mutants to prospectively test network predictions.
Related work:
BMC Systems Biology 2012,
BMC Systems Biology 2014,
bioRxiv 099036
Nov 2013: Our proposal "Inference of Gene Networks Studying Human Cancers On The Cloud" won Microsoft's Windows Azure for Research Award.
From computational discoveries to translational research:
The development of genetic predictors of clinical outcomes contributes
to risk assessment in personalized medicine.
In collaboration with Dr. Jerry Radich and Dr. Vivian Oehler at the
Fred Hutchinson Cancer Research Center, we aim to develop computational
models that can predict patient responses to therapy at diagnosis,
which allow us to tailor therapy to individual patients of
chonic myeloid leukemia (CML).
We have previously applied Bayesian Model Averaging to a gene expression
data studying the progression of CML, and identified 6 predictive genes
in
Blood 2009.
Building on this work, we developed a network-driven approach that
uses expert knowledge and predicted functional relationships to guide
our search for signature genes in the
March 2012 issue of Bioinformatics.
We showed that our gene signatures of advanced phase CML are predictive of relapse even after adjustment for known risk factors associated with transplant outcomes.
Pattern discovery and feature selection: I have also contributed to the development and application of pattern discovery and feature selection in computational biology, including clustering algorithms and supervised learning methods.